Stay updated on FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor update to the page metadata.
    Difference
    0.0%
    Check dated 2026-06-06T23:39:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a newer build/version of the page. No changes to the study information are indicated.
    Difference
    0.0%
    Check dated 2026-05-16T08:42:38.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page’s revision/build label was incremented from v3.5.2 to v3.5.3, indicating an implementation update without changing the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-25T05:25:49.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T00:16:37.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T01:32:06.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision updated to v3.4.3. The previous revision v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T21:32:26.000Z thumbnail image

Stay in the know with updates to FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-02: Derazantinib & Atezolizumab in Urothelial Cancer Clinical Trial page.